03/18/2025
4:00 PM | Petros Pharmaceuticals (Filer)
| Form DEF 14A | |
03/07/2025
4:06 PM | Petros Pharmaceuticals (Filer)
| Form PRE 14A | |
02/26/2025
8:16 AM | Iroquois Capital Management, LLC (Filed by)
Petros Pharmaceuticals (Subject)
| Form SCHEDULE 13G | |
02/21/2025
4:30 PM | Bernstein Bruce (Reporting)
Petros Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2025
4:31 PM | Boctor Fady (Reporting)
Petros Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2025
4:33 PM | Petros Pharmaceuticals (Issuer)
Silverman Joshua (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2025
4:34 PM | Arnold Mitchell (Reporting)
Petros Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2025
4:36 PM | Petros Pharmaceuticals (Issuer)
WALKER WAYNE REMELL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2025
4:15 PM | Petros Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/19/2025
4:22 PM | Petros Pharmaceuticals (Filer)
| Form 424B4 | |
02/17/2025
11:15 PM | Petros Pharmaceuticals (Filer)
| Form EFFECT | |
Get the Latest News and Ratings for PTPI and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Petros Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. |
02/14/2025
7:55 PM | Petros Pharmaceuticals (Filer)
| Form S-1MEF | |
02/14/2025
10:28 AM | Petros Pharmaceuticals (Filer)
| Form S-1/A | |
02/13/2025
12:44 PM | Ayrton Capital LLC (Filed by)
Petros Pharmaceuticals (Subject)
| Form SCHEDULE 13G/A | |
02/13/2025
8:42 AM | Petros Pharmaceuticals (Filer)
| Form S-1/A | |
12/16/2024
4:15 PM | Petros Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/21/2024
3:57 PM | Petros Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/18/2024
3:21 PM | Petros Pharmaceuticals (Filer)
| Form DEFA14A | |
11/13/2024
4:11 PM | Petros Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/13/2024
10:14 AM | INTRACOASTAL CAPITAL, LLC (Filed by)
Petros Pharmaceuticals (Subject)
| Form SC 13G/A | |
10/25/2024
4:00 PM | Petros Pharmaceuticals (Filer)
| Form DEF 14A | |
10/25/2024
4:02 PM | Petros Pharmaceuticals (Filer)
| Form ARS | |
10/18/2024
4:00 PM | Petros Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/17/2024
4:07 PM | Petros Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/15/2024
4:19 PM | Petros Pharmaceuticals (Filer)
| Form PRE 14A | |
10/04/2024
4:15 PM | Petros Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/19/2024
3:05 PM | Petros Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/20/2024
11:15 PM | Petros Pharmaceuticals (Filer)
| Form EFFECT | |
05/15/2024
4:00 PM | Petros Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/01/2024
3:31 PM | Petros Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
